Youliang Weng

643 total citations
34 papers, 441 citations indexed

About

Youliang Weng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Youliang Weng has authored 34 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Youliang Weng's work include Spectroscopy Techniques in Biomedical and Chemical Research (9 papers), Ferroptosis and cancer prognosis (7 papers) and Gold and Silver Nanoparticles Synthesis and Applications (7 papers). Youliang Weng is often cited by papers focused on Spectroscopy Techniques in Biomedical and Chemical Research (9 papers), Ferroptosis and cancer prognosis (7 papers) and Gold and Silver Nanoparticles Synthesis and Applications (7 papers). Youliang Weng collaborates with scholars based in China, Taiwan and United States. Youliang Weng's co-authors include Sufang Qiu, Wanzun Lin, Yuhui Pan, Shihong Wu, Duo Lin, Long Chen, Xianxin Qiu, Shangyuan Feng, Xiaochuan Chen and Yuling Ye and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Youliang Weng

28 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youliang Weng China 12 213 130 96 96 84 34 441
Chuanzhen Hu China 17 311 1.5× 193 1.5× 107 1.1× 111 1.2× 114 1.4× 36 694
Joseph Carmicheal United States 8 145 0.7× 86 0.7× 78 0.8× 68 0.7× 131 1.6× 14 351
Dan Eniu Romania 11 203 1.0× 124 1.0× 41 0.4× 62 0.6× 71 0.8× 38 427
Thomas J. Metzner United States 7 192 0.9× 86 0.7× 115 1.2× 161 1.7× 88 1.0× 17 459
Changliang Luo China 14 361 1.7× 234 1.8× 64 0.7× 206 2.1× 82 1.0× 19 645
Yuanji Xu China 17 377 1.8× 210 1.6× 98 1.0× 130 1.4× 211 2.5× 70 893
Cathy Spillane Ireland 12 249 1.2× 181 1.4× 43 0.4× 108 1.1× 160 1.9× 20 560
Huifang Huang China 10 151 0.7× 57 0.4× 30 0.3× 57 0.6× 60 0.7× 39 362
Afroditi Nanou Netherlands 10 258 1.2× 172 1.3× 56 0.6× 112 1.2× 150 1.8× 20 460
F Piccotti Italy 12 213 1.0× 126 1.0× 27 0.3× 84 0.9× 121 1.4× 23 408

Countries citing papers authored by Youliang Weng

Since Specialization
Citations

This map shows the geographic impact of Youliang Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youliang Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youliang Weng more than expected).

Fields of papers citing papers by Youliang Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youliang Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youliang Weng. The network helps show where Youliang Weng may publish in the future.

Co-authorship network of co-authors of Youliang Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Youliang Weng. A scholar is included among the top collaborators of Youliang Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youliang Weng. Youliang Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Zijie, S. C. Hou, Sufang Qiu, Youliang Weng, & Duo Lin. (2025). Detection of human saliva using surface-enhanced Raman spectroscopy combined with fractionation processing and machine learning for noninvasive screening of nasopharyngeal carcinoma. Journal of Innovative Optical Health Sciences. 19(1).
2.
Li, Ying, et al.. (2025). Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival. JCO Precision Oncology. 9(9). e2400603–e2400603.
3.
4.
Chen, Xiaochuan, Zhengjin Jiang, Junping Pan, et al.. (2025). Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy. BMC Cancer. 25(1). 773–773.
5.
Weng, Youliang, Yun Xu, Yuhui Pan, et al.. (2024). Selection of induction chemotherapy cycles for stage N3 nasopharyngeal carcinoma based on pre-treatment plasma EBV DNA. Scientific Reports. 14(1). 24484–24484.
6.
Zhang, Jun, Youliang Weng, Yi Liu, et al.. (2024). Molecular separation-assisted label-free SERS combined with machine learning for nasopharyngeal cancer screening and radiotherapy resistance prediction. Journal of Photochemistry and Photobiology B Biology. 257. 112968–112968. 6 indexed citations
7.
Fan, Min, Youliang Weng, Yi Liu, et al.. (2024). Surface‐Enhanced Raman Spectroscopy‐Based Optical Biosensor for Liquid Biopsy: Toward Precision Medicine. Laser & Photonics Review. 18(5). 16 indexed citations
8.
Weng, Youliang, Ying Li, Jing Wang, et al.. (2024). Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein–Barr virus DNA. Therapeutic Advances in Medical Oncology. 16. 12731225–12731225. 1 indexed citations
9.
Weng, Youliang, Ying Li, Wanzun Lin, et al.. (2024). Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 12(10). e009893–e009893. 1 indexed citations
10.
Fan, Min, Youliang Weng, Yuanmei Chen, et al.. (2024). LC-MS/MS-assisted label-free SERS blood analysis by self-position plasmonic platform for tumor screening. Chemical Engineering Journal. 483. 149348–149348. 20 indexed citations
11.
12.
Li, Ying, Wei Liu, Yun Xu, et al.. (2023). Impact of Radiotherapy Combined With Chemotherapy on Long-Term Outcomes of Patients With Recurrent Nasopharyngeal Carcinoma. Technology in Cancer Research & Treatment. 22. 2223897609–2223897609. 2 indexed citations
13.
14.
Lin, Jinyong, Youliang Weng, Xueliang Lin, et al.. (2022). Highly Efficient Blood Protein Analysis Using Membrane Purification Technique and Super-Hydrophobic SERS Platform for Precise Screening and Staging of Nasopharyngeal Carcinoma. Nanomaterials. 12(15). 2724–2724. 6 indexed citations
15.
Zhu, Youzhi, Xueliang Lin, Kien Voon Kong, et al.. (2022). Optical biosensor based on SERS with signal calibration function for quantitative detection of carcinoembryonic antigen. Biomedical Optics Express. 13(11). 5962–5962. 9 indexed citations
16.
Huang, Jing, et al.. (2022). A Novel Necroptosis-Associated IncRNAs Signature for Prognosis of Head and Neck Squamous Cell Carcinoma. Frontiers in Genetics. 13. 907392–907392. 2 indexed citations
17.
Huang, Zongwei, Ying Li, Xiaochuan Chen, et al.. (2021). Identification of a ferroptosis-associated gene signature and the related therapeutic targets in head and neck squamous carcinoma. International Immunopharmacology. 102. 108431–108431. 7 indexed citations
18.
Li, Ying, Youliang Weng, Yuhui Pan, et al.. (2021). A Novel Prognostic Signature Based on Metabolism-Related Genes to Predict Survival and Guide Personalized Treatment for Head and Neck Squamous Carcinoma. Frontiers in Oncology. 11. 685026–685026. 11 indexed citations
19.
Qiu, Sufang, Miaomiao Li, Jun Liu, et al.. (2020). Study on the chemodrug-induced effect in nasopharyngeal carcinoma cells using laser tweezer Raman spectroscopy. Biomedical Optics Express. 11(4). 1819–1819. 15 indexed citations
20.
Zong, Jingfeng, Bijuan Chen, Qiaojuan Guo, et al.. (2019). Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma. Radiation Oncology. 14(1). 182–182. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuanzhen Hu Breakdown of academic impact, for papers by Joseph Carmicheal Breakdown of academic impact, for papers by Dan Eniu Breakdown of academic impact, for papers by Thomas J. Metzner Breakdown of academic impact, for papers by Changliang Luo Breakdown of academic impact, for papers by Yuanji Xu Breakdown of academic impact, for papers by Cathy Spillane Breakdown of academic impact, for papers by Huifang Huang Breakdown of academic impact, for papers by Afroditi Nanou Breakdown of academic impact, for papers by F Piccotti
Rankless by CCL
2026